SynthesisAmerican journal of preventive medicine2017
A Systematic Review of Economic Evidence on Community Hypertension Interventions.
Synthesis in American journal of preventive medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05479097 (A Feasibility Study of a Novel mHealth Clinical Decision Support Application to Enable Community Health Workers to Manage Hypertension With Remote Physician Supervision), which is not on this map. Cited by 33 papers, 3 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
A Feasibility Study of a Novel mHealth Clinical Decision Support Application to Enable Community Health Workers to Manage Hypertension With Remote Physician Supervision
Who cites it
33 citing papers in PubMed, 3 syntheses or guidelines pooled it, 43 citations in OpenAlex.
- Lay advisor interventions for hypertension outcomes: A Systematic Review, Meta-analysis and a RE-AIM evaluation.Frontiers in medicine · 2024Pooled it
- [Organization and costs of stroke care in outpatient settings: Systematic review].Atencion primaria · 2023Pooled it
- Systematic Review of Self-Measured Blood Pressure Monitoring With Support: Intervention Effectiveness and Cost.American journal of preventive medicine · 2022Pooled it
- Cost-effectiveness of the simplified multicomponent primary care management of cardiovascular risk in Tibet, China: a within-trial and modeled economic evaluation.Journal of human hypertension · 2026Trial
- Effectiveness of a community-based education and peer support led by women's self-help groups in improving the control of hypertension in urban slums of Kerala, India: a cluster randomised controlled pragmatic trial.BMJ global health · 2022Trial
- Cost-Effectiveness of Community-Based Interventions for Hypertension Prevention and Management: A Protocol for Systematic Review, Meta-Analysis, and Quality Assessment.JNMA; journal of the Nepal Medical Association · 2025Article
- Article
- A cluster randomised controlled trial of community groups using Participatory Learning and Action to prevent and control diabetes and intermediate hyperglycaemia in rural Bangladesh.PLOS global public health · 2025Article
- Article
- Exploring various models of health coaching for improving blood pressure control among patients with hypertension attending primary health care settings: A scoping review.Malaysian family physician : the official journal of the Academy of Family Physicians of Malaysia · 2025Review
- Using electronic health record data for chronic disease surveillance in low- and middle-income countries: the example of hypertension in rural Guatemala.Healthcare in low-resource settings · 2024Article
- Cost-utility analysis of community-based interventions for hypertension control in Vietnam.Research square · 2024Article
- Cost-Effectiveness Analysis of Personalized Hypertension Prevention.Journal of personalized medicine · 2023Article
- The costs associated with stroke care continuum: a systematic review.Health economics review · 2023Review
- Article
- Cost-Effectiveness of Recommendations From the Surgeon General's Call-to-Action to Control Hypertension.American journal of hypertension · 2022Review
- Cost Effectiveness of a Cultural Physical Activity Intervention to Reduce Blood Pressure Among Native Hawaiians with Hypertension.PharmacoEconomics - open · 2022Article
- Combining econometric analysis and simulation modeling to evaluate Population-Based health policies for chronic disease prevention and control.Preventive medicine reports · 2021Article
- Prioritizing Community-Based Intervention Programs for Improving Treatment Compliance of Patients with Chronic Diseases: Applying an Analytic Hierarchy Process.International journal of environmental research and public health · 2021Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 2 institutions in 1 country.
Funding
Abstract
contextEffective community-based interventions are available to control hypertension. It is important to determine the economics of these interventions. EVIDENCE ACQUISITION: Peer-reviewed studies from January 1995 through December 2015 were screened. Interventions were categorized into educational interventions, self-monitoring interventions, and screening interventions. Incremental cost-effectiveness ratios were summarized by types of interventions. The review was conducted in 2016. EVIDENCE SYNTHESIS: Thirty-four articles were included in the review (16 from the U.S., 18 from other countries), including 25 on educational interventions, three on self-monitoring interventions, and six on screening interventions. In the U.S., five (31.3%) studies on educational interventions were cost saving. Among the studies that found the interventions cost effective, the median incremental costs were $62 (range, $40-$114) for 1-mmHg reduction in systolic blood pressure (SBP) and $13,986 (range, $6,683-$58,610) for 1 life-year gained. Outside the U.S., educational interventions cost from $0.62 (China) to $29 (Pakistan) for 1-mmHg reduction in SBP. Self-monitoring interventions, evaluated in the U.S. only, cost $727 for 1-mmHg reduction in SBP and $41,927 for 1 life-year gained. For 1 quality-adjusted life-year, screening interventions cost from $21,734 to $56,750 in the U.S., $613 to $5,637 in Australia, and $7,000 to $18,000 in China. Intervention costs to reduce 1 mmHg blood pressure or 1 quality-adjusted life-year were higher in the U.S. than in other countries.
conclusionsMost studies found that the three types of interventions were either cost effective or cost saving. Quality of economic studies should be improved to confirm the findings.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.